Novo Sues Hims Over Obesity Drug Copycats
Novo Nordisk has filed a lawsuit against Hims & Hers Health alleging patent infringement on semaglutide, escalating tensions between the companies after their partnership dissolved last year.
Category : Pharmaceuticals
Health Canada Recalls Blood Pressure Medication Over Mix-Up
Health Canada has issued a Canada-wide recall for MAR-Amlodipine 5 mg tablets after discovering some bottles contain the wrong drug, posing serious health risks including dangerously high blood pressure and organ damage.
Health Canada Recalls Blood Pressure Drugs: Check Your Meds
Health Canada has announced a recall for specific lots of Midodrine and MAR-Amlodipine tablets used to treat low and high blood pressure. Patients are urged to verify their prescriptions immediately.
Blood Pressure Drug Recall After Pill Mix-Up in Canada
Health Canada has announced a recall for specific blood pressure medications due to a packaging error that led to pill mix-ups between two different drugs.
Novo Nordisk Surges as Hims Pulls Weight Loss Pill
Novo Nordisk shares experience a significant surge following news that Hims & Hers has withdrawn its $49 weight loss pill from the U.S. market due to FDA pressure, impacting competitive dynamics.
Novo Nordisk Shares Rebound After FDA Action on Drug Copies
Shares of pharmaceutical giant Novo Nordisk have rebounded following a U.S. FDA announcement targeting illegal copies of its drugs, amid broader market and regulatory developments.
Hims & Hers Faces Legal Threat Over Wegovy Copy
Novo Nordisk threatens legal action against Hims & Hers for launching a generic version of its weight-loss drug Wegovy, escalating tensions in the pharmaceutical industry.
Lilly and Novo's Split Obesity Outlook Shakes Wall Street
Eli Lilly and Novo Nordisk present contrasting financial forecasts for their weight loss drugs, revealing strategic differences in patent life, marketing, and market positioning.
Novo Nordisk to Launch Ozempic Pill in Q2 2026
Novo Nordisk announces the launch of its oral semaglutide medication, branded as Ozempic pill, for diabetes treatment starting in the second quarter of 2026.
Lilly Beats Earnings Estimates on Weight-Loss Drug Boom
Eli Lilly reports strong quarterly earnings, exceeding analyst forecasts, and issues an optimistic outlook driven by unprecedented demand for its weight-loss medications.
Pfizer Weight-Loss Drug Data Sparks Safety Concerns
New clinical data from Pfizer's weight-loss drug candidate has raised significant questions about potential side effects, leading to a notable drop in the company's share price.
Wegovy Pill Prescriptions Hit 18,410 in First Week
Novo Nordisk's new Wegovy weight-loss pill recorded 18,410 prescriptions in its first full week post-launch, signaling robust early demand in the pharmaceutical market.
Canada Warns of Fake Ozempic, Mounjaro Drugs
Health Canada alerts the public about dangerous counterfeit versions of diabetes and weight-loss medications Ozempic and Mounjaro circulating in the market.
Inside Calgary's massive psychedelics drug lab
Calgary's Psygen Labs, a federally licensed facility, manufactures pharmaceutical-grade psychedelics like psilocybin and MDMA for global research, aiming to address mental health and addiction.
Generic Ozempic Arrives in Canada, Prices to Drop
The patent for semaglutide (Ozempic) has expired in Canada, paving the way for affordable generic versions. This could dramatically increase access to weight-loss and diabetes medications.
TekniPlex Expands Pharma Packaging at Paris Pharmapack
TekniPlex Healthcare will showcase expanded multidose vial production and advanced barrier materials at Pharmapack 2026 in Paris, highlighting innovations for ophthalmic and sterile applications.
Partnership Targets $6B Fridge-Free Drug Market
Stablepharma and AFT Pharmaceuticals partner to develop fridge-free injectables for anti-infective and oncology markets. Read about this innovation set to transform global medicine access.
Generic Ozempic May Cut Prices by a Third in Canada
A Calgary doctor predicts generic versions of Ozempic and Wegovy could reduce costs by up to a third. Learn about the patent expiry and five companies seeking approval to manufacture cheaper alternatives in Canada.
Northwest Edmonton Pharmacist Suspended, Fined
A pharmacist in northwest Edmonton has been suspended and fined for professional misconduct. Get the details on the sanctions from the Alberta College of Pharmacists.
Generic Ozempic, Wegovy Coming to B.C. Soon
Health Canada reviews nine generic semaglutide submissions. Cheaper versions of Ozempic and Wegovy could soon improve access for diabetes and weight loss patients in British Columbia.
Novo Nordisk flags near-term headwinds in global markets
Danish pharmaceutical giant Novo Nordisk signals upcoming challenges in international markets. Get the latest business insights and analysis on this developing story.
Ozempic Goes Generic in Canada, Prices to Drop
Semaglutide, sold as Ozempic, is now off-patent in Canada. This move could slash costs by up to 75%, dramatically increasing access to the popular diabetes and weight-loss drug for Canadians.
AI Partnership Aims to Design Clinical Trials in One Day
Citeline and Risklick partner to transform clinical trial design with AI, aiming to reduce costly amendments and accelerate drug development timelines for Canadian researchers.
1.5M U.S. Patients Using Compounded GLP-1 Drugs: Novo CEO
The CEO of Novo Nordisk disclosed that an estimated 1.5 million Americans are using compounded versions of GLP-1 drugs. Learn about the market implications and safety concerns.
Novo CEO: Obesity Pill Opens Doors to New Markets
Novo Nordisk's CEO says its new obesity pill will tap into millions not using GLP-1s due to needle fears. The drugmaker battles Eli Lilly and compounders in a massive market.
Fake Erectile Dysfunction Drugs Found in Mississauga
Health Canada issues a public warning about counterfeit Viagra and Cialis tablets found at a Mississauga distributor. Learn how to identify fake medications and protect your health.
First Alzheimer's Fighting Infusion Delivered in Canada
A newly approved Alzheimer's drug has been administered for the first time in Canada, providing fresh hope to patients. However, significant questions about coverage costs remain unresolved.
Kilos Return Fast After Stopping Weight-Loss Drugs: Study
New research shows patients quickly regain weight after ending GLP-1 medications like Wegovy. Experts stress the need for long-term lifestyle strategies. Learn the findings.
Ozempic price drop in Quebec after patent expiry
Generic versions of weight-loss drug Ozempic could slash costs from $400 to under $100 per month in Quebec following a key patent expiration, potentially increasing access for hundreds of thousands.
Canadian Platform to Offer India-Sourced Ozempic to US
A Canadian pharmacy platform plans to supply US patients with Ozempic sourced from India starting in 2026, creating a new cross-border pharmaceutical channel. Learn the details and implications.
Page 1 of 3